BSI Life Sciences announces the release of its latest version of Clinical Trial Management System 7.0
BSI Life Sciences announced the launch of BSI CTMS (Clinical Trial Management System) 7.0. The newest version of the eCl…
Newsrooms
Avisa Diagnostics Begins Trading on the Canadian Securities Exchange
. - Public Listing offers Access to CAD 52 Million from Share Subscription and Drawdown Agreement, Sufficient Funding to…
Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral thera…
Curetis Announces Intention to Launch Its Initial Public Offering and Listing on Euronext Amsterdam and Euronext Brussels
Curetis AG ("Curetis"), a developer of next-level molecular diagnostic solutions, today announces its intention to launc…
Rodos BioTarget Receives Growth Financing of EUR 2.6 m
Rodos BioTarget GmbH (RBT) is pleased to announce that it has in 2012 successfully realized corporate investment actions…
Profits up for the 17th consecutive year in 2012: +13.6% after minority interests
The Galenica Group recorded profit growth for the 17th consecutive year in 2012: consolidated net profit rose 13.6% to C…
Roche Launches New PCR Assay for Tuberculosis Testing in South Africa
Roche Diagnostics today announced the launch of a new tuberculosis test for South Africa. Worldwide, South Africa is one…
Clinical Imaging Research Centre in Kooperation mit Siemens Medical Solutions in Singapur
Die National University of Singapur und A*STAR (Agency for Science, Technology and Research) gaben heute die Eröffnung e…